Bogart Wealth LLC Has $14.40 Million Holdings in CME Group Inc. (NASDAQ:CME)

Bogart Wealth LLC boosted its stake in CME Group Inc. (NASDAQ:CME) by 10.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,256 shares of the financial services provider’s stock after purchasing an additional 6,330 shares during the period. CME Group comprises approximately 0.7% of Bogart Wealth LLC’s investment portfolio, making the stock its 29th biggest position. Bogart Wealth LLC’s holdings in CME Group were worth $14,399,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Brookstone Capital Management boosted its position in CME Group by 3.4% during the first quarter. Brookstone Capital Management now owns 27,230 shares of the financial services provider’s stock valued at $5,862,000 after acquiring an additional 903 shares during the last quarter. Fifth Third Wealth Advisors LLC lifted its stake in shares of CME Group by 224.6% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 4,531 shares of the financial services provider’s stock valued at $976,000 after purchasing an additional 3,135 shares during the period. Artemis Investment Management LLP boosted its position in shares of CME Group by 32.6% during the 1st quarter. Artemis Investment Management LLP now owns 55,342 shares of the financial services provider’s stock valued at $11,908,000 after purchasing an additional 13,598 shares in the last quarter. Trifecta Capital Advisors LLC grew its stake in CME Group by 2.6% during the first quarter. Trifecta Capital Advisors LLC now owns 6,175 shares of the financial services provider’s stock worth $1,329,000 after purchasing an additional 159 shares during the period. Finally, Hennion & Walsh Asset Management Inc. increased its holdings in CME Group by 83.0% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 7,630 shares of the financial services provider’s stock worth $1,643,000 after purchasing an additional 3,461 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently commented on CME shares. Citigroup raised their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday. Piper Sandler increased their price objective on shares of CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 8th. Keefe, Bruyette & Woods boosted their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. The Goldman Sachs Group raised their price objective on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Finally, Morgan Stanley increased their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $222.07.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Price Performance

NASDAQ:CME traded up $2.51 during mid-day trading on Thursday, hitting $229.65. 420,210 shares of the stock traded hands, compared to its average volume of 1,930,872. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.30. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $82.69 billion, a PE ratio of 26.06, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The business’s 50-day moving average price is $218.08 and its 200 day moving average price is $208.66.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the previous year, the business earned $2.25 EPS. On average, analysts expect that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.00%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.